Summary information:
Available credit: 4.00 Category 1 credits for allied healthcare professionals
Course opens: 09/01/2024
Course expires: No expiration date is currently scheduled
Dr. Ronald M. Krauss, MD, Professor of Medicine at UCSF and Adjunct Professor of Nutritional Sciences at UC Berkeley, and Nina Teicholz, PhD, author and science journalist, co-organized this course on Dietary Approaches to Reversing Type 2 Diabetes. The course is offered as a legacy to the late Dr. Sarah Hallberg, a pioneer in the research and promotion of putting type 2 (T2) diabetes into remission—or “reversal” of the disease, as she preferred to describe the process of restoring average blood sugar (A1c) to normal levels while eliminating the need for all or most medications.
Contrary to the common belief that type 2 diabetes is a lifelong, ever-worsening progressive and chronic condition, the disease can be put into remission, sustainably, through changes in diet alone. This course addresses the science and practice of the nutritional therapies that achieve these results.
The course covers the definitions of remission and “reversal,” the definition and pathophysiology of type 2 diabetes, the metabolic basis for low-carbohydrate and ketogenic diets, a review of the clinical trial evidence for T2 reversal through dietary approaches, the practical approaches to implementing and maintain low-carbohydrate diets, and a review of patient cases, as well as a panel discussion with audience questions.
The faculty presenting are some of the top researchers in the field, including Jeff Volek, PhD, RD, a Professor at The Ohio State University; Dr Tony Hampton, MD, MBA, MS-HNFM, ABOM, a doctor in Chicago who is board certified in Family and Obesity Medicine as well as Advocate Midwest Primary Care Service Line Leader South Region Chicago; Benjamin Bikman, PhD, a Professor in the Department of Cell Biology and Physiology and Director of the Diabetes Research Lab at Brigham Young University; Ronesh Sinha, MD, the Medical Director of Metabolic Wellness Program at Sutter Health; and Laura Saslow, PhD, an Associate Professor at the University of Michigan.
For those interested in Dr. Sarah Hallberg’s memoir, mentioned in the course, it is available for purchase on Amazon.
This educational activity is for both a general audience including people living with diabetes and healthcare professionals worldwide, including primary care clinicians (PCPs), endocrinologists cardiologists, lipidologists, dieticians, nutritionists, registered nurses, advanced practice registered nurses, and other allied health professionals involved in the management and treatment of diabetes and its related conditions.
After completing this activity, the participant should be better able to:
4.5 hours. The first 30 minutes of the course (welcome and introductions) are not available for credit.
CPD Standards Office designates this enduring material for a maximum of 4.0 credits, Category 1. Healthcare professionals should claim only the credit commensurate with the extent of their participation in the activity. All Allied Healthcare Professionals may obtain credits; however, you might check that your governing body will approve these credits. Any questions or requests for help in securing credit should be directed to: support@thesmhp.org.
There are no fees for this activity. Participation in this self-study activity should be completed in approximately 4.5 hours. To successfully complete this activity and receive CME credit, learners must follow these steps:
You must respond to all evaluation questions to receive a certificate. Upon completion, your certificate will be available for print. For questions about receiving certificates,please contact support@thesmhp.org.
The CPD Standards Office requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated according to CPD Standards Office. All others involved in the planning or presentation of this activity report no conflicts of interest. Jeff Volek reports owning stock in Virta Health, a diabetes reversal company.
Become a part of our community dedicated to advancing metabolic health. Sign up today to gain access to specialized content, connect with fellow practitioners, and contribute to the future of metabolic health. Your journey starts here!
Log in to access your profile and membership content